189 related articles for article (PubMed ID: 37429271)
1. Clinicopathological Characteristics and Impacts on Clinical Outcomes of Thrombotic Microangiopathy Lesions in Patients with Immunoglobulin A Nephropathy in Thailand.
Puapatanakul P; Banjongjit A; Kanjanabuch T; Surintrspanont J; Iampenkhae K; Praditpornsilpa K; Eiam-Ong S; Boonpucknavig V
Am J Nephrol; 2023; 54(7-8):308-318. PubMed ID: 37429271
[TBL] [Abstract][Full Text] [Related]
2. Evidences of histologic thrombotic microangiopathy and the impact in renal outcomes of patients with IgA nephropathy.
Neves PDMM; Souza RA; Torres FM; Reis FA; Pinheiro RB; Dias CB; Yu L; Woronik V; Furukawa LS; Cavalcante LB; de Almeida Araújo S; Wanderley DC; Malheiros DM; Jorge LB
PLoS One; 2020; 15(11):e0233199. PubMed ID: 33147224
[TBL] [Abstract][Full Text] [Related]
3. Clinical and Histopathological Profile of Immunoglobulin A Nephropathy Patients in Central Part of India: A Single-Center Study.
Balwani MR; Pasari A; Bhawane A; Tolani P
Saudi J Kidney Dis Transpl; 2022; 33(2):307-312. PubMed ID: 37417183
[TBL] [Abstract][Full Text] [Related]
4. Prognostic role of glomerular electron microscopy lesions in IgA nephropathy: "the devil is in the details".
Terinte-Balcan G; Stancu S; Zugravu A; Capusa C; Radu A; Mircescu G; Stefan G
J Nephrol; 2023 Nov; 36(8):2233-2243. PubMed ID: 37632668
[TBL] [Abstract][Full Text] [Related]
5. A validation study of crescents in predicting ESRD in patients with IgA nephropathy.
Zhang X; Shi S; Ouyang Y; Yang M; Shi M; Pan X; Lv J; Wang Z; Ren H; Shen P; Wang W; Zhang H; Xie J; Chen N
J Transl Med; 2018 May; 16(1):115. PubMed ID: 29724226
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for progression in children and young adults with IgA nephropathy: an analysis of 261 cases from the VALIGA European cohort.
Coppo R; Lofaro D; Camilla RR; Bellur S; Cattran D; Cook HT; Roberts IS; Peruzzi L; Amore A; Emma F; Fuiano L; Berg U; Topaloglu R; Bilginer Y; Gesualdo L; Polci R; Mizerska-Wasiak M; Caliskan Y; Lundberg S; Cancarini G; Geddes C; Wetzels J; Wiecek A; Durlik M; Cusinato S; Rollino C; Maggio M; Praga M; K Smerud H; Tesar V; Maixnerova D; Barratt J; Papalia T; Bonofiglio R; Mazzucco G; Giannakakis C; Soderberg M; Orhan D; Di Palma AM; Maldyk J; Ozluk Y; Sudelin B; Tardanico R; Kipgen D; Steenbergen E; Karkoszka H; Perkowska-Ptasinska A; Ferrario F; Gutierrez E; Honsova E
Pediatr Nephrol; 2017 Jan; 32(1):139-150. PubMed ID: 27557557
[TBL] [Abstract][Full Text] [Related]
7. The Added Value of Crescents on Oxford Classification Score in Risk Stratification of End-stage Kidney Disease in Patients with IgA Nephropathy.
Ossareh S; Nazemzadeh N; Asgari M; Bagherzadegan H; Afghahi H
Iran J Kidney Dis; 2022 Mar; 16(2):115-124. PubMed ID: 35489080
[TBL] [Abstract][Full Text] [Related]
8. A clinicopathologic study of thrombotic microangiopathy in IgA nephropathy.
El Karoui K; Hill GS; Karras A; Jacquot C; Moulonguet L; Kourilsky O; Frémeaux-Bacchi V; Delahousse M; Duong Van Huyen JP; Loupy A; Bruneval P; Nochy D
J Am Soc Nephrol; 2012 Jan; 23(1):137-48. PubMed ID: 22052055
[TBL] [Abstract][Full Text] [Related]
9. Is it possible to predict parameters of the Oxford classification of primary IgA Nephropathy from clinical laboratory data? Focus on the role of segmental glomerulosclerosis subtypes.
Monteiro MLGDR; Vieira MR; Pereira LHM; Araújo LS; Silva CA; Araújo LB; Rocha LP; Reis MAD; Machado JR
Pathol Res Pract; 2019 Oct; 215(10):152533. PubMed ID: 31320251
[TBL] [Abstract][Full Text] [Related]
10. Clinical and histopathologic profile of patients with primary IgA nephropathy seen in a tertiary hospital in India.
Bagchi S; Singh G; Yadav R; Kalaivani M; Mahajan S; Bhowmik D; Dinda A; Agarwal SK
Ren Fail; 2016; 38(3):431-6. PubMed ID: 26837482
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of the Oxford classification and the Oxford score in IgA nephropathy: A Tunisian study.
Jebali H; Ghabi H; Mami I; Kaab BB; Fatma LB; Smaoui W; Haouet S; Mahjouba HB; Hassan M; Hmida FB; Raies L; Zouaghi MK
Saudi J Kidney Dis Transpl; 2020; 31(6):1366-1375. PubMed ID: 33565449
[TBL] [Abstract][Full Text] [Related]
12. The use of the Oxford classification of IgA nephropathy to predict renal survival.
Alamartine E; Sauron C; Laurent B; Sury A; Seffert A; Mariat C
Clin J Am Soc Nephrol; 2011 Oct; 6(10):2384-8. PubMed ID: 21885791
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the Oxford Classification of IgA nephropathy: a systematic review and meta-analysis.
Lv J; Shi S; Xu D; Zhang H; Troyanov S; Cattran DC; Wang H
Am J Kidney Dis; 2013 Nov; 62(5):891-9. PubMed ID: 23820066
[TBL] [Abstract][Full Text] [Related]
14. IgA nephropathy clinicopathologic study following the Oxford classification: Progression peculiarities and gender-related differences.
Riispere Ž; Laurinavičius A; Kuudeberg A; Seppet E; Sepp K; Ilmoja M; Luman M; Kõlvald K; Auerbach A; Ots-Rosenberg M
Medicina (Kaunas); 2016; 52(6):340-348. PubMed ID: 27932191
[TBL] [Abstract][Full Text] [Related]
15. Value of the Oxford classification of IgA nephropathy in children with Henoch-Schönlein purpura nephritis.
Xu K; Zhang L; Ding J; Wang S; Su B; Xiao H; Wang F; Zhong X; Li Y
J Nephrol; 2018 Apr; 31(2):279-286. PubMed ID: 29185209
[TBL] [Abstract][Full Text] [Related]
16. Is there long-term value of pathology scoring in immunoglobulin A nephropathy? A validation study of the Oxford Classification for IgA Nephropathy (VALIGA) update.
Coppo R; D'Arrigo G; Tripepi G; Russo ML; Roberts ISD; Bellur S; Cattran D; Cook TH; Feehally J; Tesar V; Maixnerova D; Peruzzi L; Amore A; Lundberg S; Di Palma AM; Gesualdo L; Emma F; Rollino C; Praga M; Biancone L; Pani A; Feriozzi S; Polci R; Barratt J; Del Vecchio L; Locatelli F; Pierucci A; Caliskan Y; Perkowska-Ptasinska A; Durlik M; Moggia E; Ballarin JC; Wetzels JFM; Goumenos D; Papasotiriou M; Galesic K; Toric L; Papagianni A; Stangou M; Benozzi L; Cusinato S; Berg U; Topaloglu R; Maggio M; Ots-Rosenberg M; D'Amico M; Geddes C; Balafa O; Quaglia M; Cravero R; Lino Cirami C; Fellstrom B; Floege J; Egido J; Mallamaci F; Zoccali C;
Nephrol Dial Transplant; 2020 Jun; 35(6):1002-1009. PubMed ID: 30418652
[TBL] [Abstract][Full Text] [Related]
17. A mixed-method evaluation of the relationship between Oxford classification scores and longitudinal changes in proteinuria in patients with immunoglobulin A nephropathy.
Xu RC; Guo JY; Cao T; Xu Y; Liao Y; Chen YN; Song HY; Chen XJ; Guan MJ; Tang F; Xiang Q; Chen XL; Wan QJ
Front Endocrinol (Lausanne); 2022; 13():890900. PubMed ID: 36704031
[TBL] [Abstract][Full Text] [Related]
18. The association of microhematuria with mesangial hypercellularity, endocapillary hypercellularity, crescent score and renal outcomes in immunoglobulin A nephropathy.
Bobart SA; Alexander MP; Shawwa K; Vaughan LE; Ghamrawi R; Sethi S; Cornell L; Glassock RJ; Fervenza FC; Zand L
Nephrol Dial Transplant; 2021 Apr; 36(5):840-847. PubMed ID: 31859353
[TBL] [Abstract][Full Text] [Related]
19. Immunoglobulin A Deposits In Renal Allografts: A Prospective Longitudinal Single-Center Study.
Ganesh K; Jayaram JK; Thomas RM; Abraham TT; Kumar JS; Simon SS; Abraham MA
Transplant Proc; 2024; 56(1):97-104. PubMed ID: 38216361
[TBL] [Abstract][Full Text] [Related]
20. Reproducibility of the Oxford classification of immunoglobulin A nephropathy, impact of biopsy scoring on treatment allocation and clinical relevance of disagreements: evidence from the VALidation of IGA study cohort.
Bellur SS; Roberts ISD; Troyanov S; Royal V; Coppo R; Cook HT; Cattran D; Arce Terroba Y; Asunis AM; Bajema I; Bertoni E; Bruijn JA; Cannata-Ortiz P; Casartelli D; Maria Di Palma A; Ferrario F; Fortunato M; Furci L; Gakiopoulou H; Galesic Ljubanovic D; Giannakakis K; Gomà M; Gröne HJ; Gutiérrez E; Asma Haider S; Honsova E; Ioachim E; Karkoszka H; Kipgen D; Maldyk J; Mazzucco G; Orhan D; Ozluk Y; Pantzaki A; Perkowska-Ptasinska A; Riispere Z; Soderberg MP; Steenbergen E; Stoppacciaro A; Sundelin Von Feilitzen B; Tardanico R
Nephrol Dial Transplant; 2019 Oct; 34(10):1681-1690. PubMed ID: 30561721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
